Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Boyer

Showing results (291-300 of 406) with videos related to

Pageof 41
Sort By:
Biorxiv : the Preprint Server for Biology|January 27, 2025
PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcomaKatrina I Paras, Julia S Brunner, Jacob A Boyer, et al.
Cell|September 13, 2005
Core transcriptional regulatory circuitry in human embryonic stem cellsLaurie A Boyer, Tong Ihn Lee, Megan F Cole, et al.
Nature|April 21, 2006
Polycomb complexes repress developmental regulators in murine embryonic stem cellsLaurie A Boyer, Kathrin Plath, Julia Zeitlinger, et al.
Cell|January 29, 2013
Braveheart, a long noncoding RNA required for cardiovascular lineage commitmentCarla A Klattenhoff, Johanna C Scheuermann, Lauren E Surface, et al.
Cancer Research Communications|September 11, 2023
A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung CancerM Dorso, Payal T Patel, Aleksandr Pankov, et al.
The Journal of Hospital Infection|August 27, 2014
Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre studyA-G Venier, C Leroyer, C Slekovec, et al.
Cancer Research|September 5, 2025
PAX3-FOXO1 Drives Targetable Cell State-Dependent Metabolic Vulnerabilities in RhabdomyosarcomaKatrina I Paras, Julia S Brunner, Angela M Montero, et al.
Cancer Research|November 1, 1996
Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanomaJ F Flores, G J Walker, J M Glendening, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 2011
1-((3S,4S)-4-amino-1-(4-substituted-1,3,5-triazin-2-yl) pyrrolidin-3-yl)-5,5-difluoropiperidin-2-one inhibitors of DPP-4 for the treatment of type 2 diabetesKim M Andrews, David A Beebe, John W Benbow, et al.
Nature|June 20, 2020
Senolytic CAR T cells reverse senescence-associated pathologiesCorina Amor, Judith Feucht, Josef Leibold, et al.
Pageof 41

Showing results (291-300 of 406) with videos related to

Sort By:
Pageof 41
Biorxiv : the Preprint Server for Biology|January 27, 2025
PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcomaKatrina I Paras, Julia S Brunner, Jacob A Boyer, et al.
Cell|September 13, 2005
Core transcriptional regulatory circuitry in human embryonic stem cellsLaurie A Boyer, Tong Ihn Lee, Megan F Cole, et al.
Nature|April 21, 2006
Polycomb complexes repress developmental regulators in murine embryonic stem cellsLaurie A Boyer, Kathrin Plath, Julia Zeitlinger, et al.
Cell|January 29, 2013
Braveheart, a long noncoding RNA required for cardiovascular lineage commitmentCarla A Klattenhoff, Johanna C Scheuermann, Lauren E Surface, et al.
Cancer Research Communications|September 11, 2023
A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung CancerM Dorso, Payal T Patel, Aleksandr Pankov, et al.
The Journal of Hospital Infection|August 27, 2014
Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre studyA-G Venier, C Leroyer, C Slekovec, et al.
Cancer Research|September 5, 2025
PAX3-FOXO1 Drives Targetable Cell State-Dependent Metabolic Vulnerabilities in RhabdomyosarcomaKatrina I Paras, Julia S Brunner, Angela M Montero, et al.
Cancer Research|November 1, 1996
Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanomaJ F Flores, G J Walker, J M Glendening, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 2011
1-((3S,4S)-4-amino-1-(4-substituted-1,3,5-triazin-2-yl) pyrrolidin-3-yl)-5,5-difluoropiperidin-2-one inhibitors of DPP-4 for the treatment of type 2 diabetesKim M Andrews, David A Beebe, John W Benbow, et al.
Nature|June 20, 2020
Senolytic CAR T cells reverse senescence-associated pathologiesCorina Amor, Judith Feucht, Josef Leibold, et al.
Pageof 41